RK Pharma Inc
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
RK Pharma Inc - overview
Established
2018
Location
New York, NY, US
Primary Industry
Pharmaceuticals
About
Founded in 2018 by Ravishanker Kovi (CEO) and based in New York, US, RK Pharma Inc operates as a vertically integrated pharmaceutical company that engages in manufacturing generic and branded medicines. In June 2023, RK Pharma Inc raised approximately USD 200 million in venture funding from new investor PAG. The firm operates from facilities in the US and India (Visakhapatnam, Andhra Pradesh and Vadodara, Gujarat) and includes subsidiaries such as Apicore, Archis Pharma, and Aktinos Pharma. Apicore and Aktinos.
The firm develops, manufactures, and sells generic pharmaceutical products with a particular focus on complex injectables. The firm also develops and offers Active Pharmaceutical Ingredients (APIs) and Intermediates. The firm sells through offline wholesalers and offers a range of tablets, vials, and ER/DR tablets. The company intends to use the June 2023 funding for business growth and acceleration as well as support research and development.
Current Investors
Signet Healthcare Partners, PAG
Primary Industry
Pharmaceuticals
Sub Industries
Specialty Pharmaceuticals, Pharmaceuticals, Pharmaceutical Research & Development
Website
www.rkpharmainc.com
Verticals
Manufacturing
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
RK Pharma Inc - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | RK Pharma Inc | - | ||||||||
| Add-on | Completed | VGYAAN Pharmaceuticals LLC | - | ||||||||
| Secondary Buyout | Completed | RK Pharma Inc | - | ||||||||
| Growth | Completed | RK Pharma Inc | - |
Displaying 1 - 4 of 4
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.